- Market Realist•3 months ago
On June 24, 2016, Pfizer (PFE) announced that it had completed the acquisition of Anacor Pharmaceuticals for a total net value of $5.2 billion. The acquisition added crisaborole.
- Market Realist•6 months ago
On June 24, Pfizer acquired Anacor Pharmaceuticals for a total enterprise value of ~$5.2 billion. Pfizer seemed to be interested in Anacor’s two major assets.
- Motley Fool•6 months ago
This boron-based biotech could open some exciting drug-development pathways for Pfizer.
Requested symbol wasn't found
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|